Bi-specific T-cell engager

Feb 21, 2020

Global Bispecific Antibody Therapeutics Market (2019 to 2030) - In-depth Analysis, Highlighting the Capabilities of Various Stakeholders Engaged in this Domain

Nov 11, 2019

Akesobio Presents Phase 1 Clinical Data from First-in-class Bispecific Drug Candidate AK104 (PD1/CTLA4) As Oral Presentation, at 2019 SITC Annual Meeting

May 15, 2019

Amgen Showcases Oncology Pipeline At ASCO 2019

Apr 18, 2019

Inovio Publishes Cancer Killing Data of Its Transformative DNA-encoded Bi-specific T Cell Engagers (dBiTEs(TM)) in a Peer-reviewed Journal

Apr 02, 2019

Inovio Presents Cancer Killing Data of Its Transformative DNA-Encoded Bi-specific T Cell Engagers (dBiTEs) at AACR

Jan 18, 2019

Global Bispecific Antibody Market to 2025: Drug Sales & Clinical Pipeline Insights with an $8 Billion Market Opportunity

Apr 18, 2018

Xencor Presents Preclinical Data on XmAb®24306, Introduces XmAb® IL15 Bispecific Platform at American Association for Cancer Research (AACR) 2018 Annual Meeting

Oct 12, 2017

Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030